Comparison of Metformin PBPK Models Incorporating Placental Transfer to Predict Fetal and Maternal Exposure

Documenti analoghi

• Impact of Obesity and MASH on Zonal Hepatocellular Statin Exposure: Pharmacodynamic Insights From a Permeability‐Limited Multicompartment Liver Model
  di: William A. Murphy, et al.
  Pubblicazione: (2025)
• Hepatic OATP1B zonal distribution: Implications for rifampicin‐mediated drug–drug interactions explored within a PBPK framework
  di: Mattie Hartauer, et al.
  Pubblicazione: (2024)
• Maximum likelihood estimation of renal transporter ontogeny profiles for pediatric PBPK modeling
  di: J. Porter Hunt, et al.
  Pubblicazione: (2024)
• Development of a Pregnancy‐Specific Physiologically Based Pharmacokinetics (PBPK) Model for Aspirin
  di: Ana Collins‐Smith, et al.
  Pubblicazione: (2026)
• PBPK Modeling to Predict Clinical Drug–Drug Interaction and Impact of Hepatic Impairment for an ADC With the Payload Auristatin F‐Hydroxypropylamide
  di: Niyanta Kumar, et al.
  Pubblicazione: (2025)